Back to discover
Drug

Fluconazole

In clinical development
Emerging researchLate-stage development

Also known as Diflucan, Difluconazole, Fluconazol, Fluconazolum.

2
Research papers
16
Active clinical trials
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Evaluation of CrAg Screening With Enhanced Antifungal Therapy for Asymptomatic CrAg+ Persons

Clinical trial2026-04-28Results expected Q2 2027 · ClinicalTrials.gov

The Drug-Drug Interaction Study of Clifutinib

Clinical trial2026-04-27Results expected Q2 2027 · ClinicalTrials.gov

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Fluconazole
Aliases & brands
DiflucanDifluconazoleFluconazolFluconazolum
RxNorm CUI
4450
ChEMBL ID
CHEMBL106
UNII
8VZV102JFY

Clinical trials

172 trials

The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.

Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY
172
registered trials across all phases
LATEST COMPLETION 2026
16
Active studies
15
Recruiting
96
Late-stage (III+)
134
Completed
22
Discontinued
PHASE DISTRIBUTIONn = 172
Early Phase 12Phase 149Phase 1 / 22Phase 223Phase 2 / 35Phase 340Phase 420Phase N / A31

Late-stage studies

Phase III+ trials still open or recently active — where late-stage evidence is being generated.

Recent completions

Trials that read out recently, adding to the completed evidence base.

Research activity

2 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Publications over time
20152016
Journals, researchers & institutions
Top journals
  • Medical mycology1
  • Mycoses1
Leading researchers
  • Fan S2
  • Li T2
  • Liang Y2
  • Liu X2
  • Zhu Y2
  • Guo X1
  • Xu H1
  • Zhou X1
Leading institutions
free-text, unnormalised
  • Department of Laboratory Science2
  • Peking University Shenzhen Hospital2
  • Postgraduate College1
  • Shenzhen Key Laboratory of Gynaecological Diagnostic Technology Research1
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature
  • ClinicalTrials.gov — clinical trials